Key player · Company profile
AbbVie Inc.
Named as a key player in 396 of our reports, across 33 regions and countries.
Named as a key player in 396 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 12
Brazil 12
Canada 12
China 12
Ecuador 12
Egypt 12
France 12
Germany 12
Hong Kong 12
India 12
Italy 12
Japan 12
Kenya 12
Malaysia 12
Mexico 12
New Zealand 12
Philippines 12
Russia 12
Saudi Arabia 12
Singapore 12
South Africa 12
Spain 12
Thailand 12
UAE 12
UK 12
US 12| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| HIV Drugs | Pharmaceuticals | $30 Bn | 5.8% |
| Dermatology Diagnostic | Healthcare Services | $26 Bn | 11.2% |
| Contraceptives Drugs | Pharmaceuticals | $25.2 Bn | 6.8% |
| Cell Based Immunotherapy | Pharmaceuticals | $16.6 Bn | 23% |
| Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs | OTC & Nutraceuticals | $14.5 Bn | 4.1% |
| Atopic Dermatitis Drugs | Pharmaceuticals | $11.2 Bn | 12.2% |
| Diabetic Retinopathy Drugs | Pharmaceuticals | $10.8 Bn | 6% |
| Over The Counter (OTC) Gastrointestinal Drugs | OTC & Nutraceuticals | $5.6 Bn | 3.9% |
| Alzheimers Dignostic | Healthcare Services | $2.1 Bn | 6.9% |
| Alopecia areata | Healthcare Services | – | – |
| Alzheimer Drugs | Pharmaceuticals | – | – |
| Axial Spondyloarthritis (axSpA) | Pharmaceuticals | – | – |
Named as key players in the same markets as AbbVie Inc. (number of shared markets).
Johnson & Johnson7 shared markets
Novartis AG5 shared markets
Eli Lilly and Company4 shared markets
F. Hoffmann-La Roche Ltd4 shared markets
Pfizer Inc.4 shared markets
Sanofi4 shared markets
AstraZeneca3 shared markets
Bayer AG3 shared markets